Belimumab after rituximab as maintenance therapy in lupus nephritis

被引：51
|
作者：
Kraaij, Tineke [1 ]
Huizinga, Tom W. J. [2 ]
Rabelink, Ton J. [1 ]
Teng, Y. K. Onno [1 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands
来源：
RHEUMATOLOGY | 2014年 / 53卷 / 11期
关键词：
ERYTHEMATOSUS; EFFICACY;
D O I：
10.1093/rheumatology/keu369
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2122 / 2124
页数：4
相关论文
共 50 条
  • [1] Rituximab-refractory lupus nephritis successfully treated with belimumab
    Gonzalez-Echavarri, C.
    Ugarte, A.
    Ruiz-Irastorza, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : 355 - 356
  • [2] The efficacy of rituximab plus belimumab or telitacicept in refractory lupus nephritis
    Chen, Yiting
    Shi, Nan
    Lei, Xin
    Ren, Pingping
    Lan, Lan
    Chen, Liangliang
    Wang, Yaomin
    Xu, Ying
    Lin, Yuxin
    Chen, Jianghua
    Han, Fei
    RHEUMATOLOGY, 2023, : 221 - 227
  • [3] Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: a real-world multicentre study
    Chen, Yiting
    Lei, Xin
    Xu, Jianhang
    Chen, Xiaochan
    Pan, Hong
    Zhang, Qiankun
    Wang, Junni
    Ren, Pingping
    Lan, Lan
    Shi, Nan
    Chen, Liangliang
    Wang, Yaomin
    Chen, Jianghua
    Jin, Lie
    Yang, Yi
    Xue, Jing
    Han, Fei
    LUPUS SCIENCE & MEDICINE, 2025, 12 (01):
  • [4] New Protocols for Treatment of Class IV Lupus Nephritis with Emphasis on Rituximab as the Sole Maintenance Therapy
    El-Reshaid, Kamel
    El-Reshaid, Wael
    Al-Bader, Shaikha
    Sallam, Hossameldin Tawfik
    Hakim, Abbass Ali
    Al-Attiyah, Rajaa
    KUWAIT MEDICAL JOURNAL, 2018, 50 (03): : 343 - 350
  • [5] Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis
    Davies, R. J.
    Sangle, S. R.
    Jordan, N. P.
    Aslam, L.
    Lewis, M. J.
    Wedgwood, R.
    D'Cruz, D. P.
    LUPUS, 2013, 22 (06) : 574 - 582
  • [6] Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis
    Hogan, Julien
    Godron, Astrid
    Baudouin, Veronique
    Kwon, Theresa
    Harambat, Jerome
    Deschenes, Georges
    Niel, Olivier
    PEDIATRIC NEPHROLOGY, 2018, 33 (01) : 111 - 116
  • [7] Rituximab use as induction therapy for lupus nephritis: a systematic review
    Stolyar, Liya
    Lahita, Robert G.
    Panush, Richard S.
    LUPUS, 2020, 29 (08) : 892 - 912
  • [8] Rituximab as Treatment for Lupus Nephritis
    Pimentel-Quiroz, Victor R.
    Reategui-Sokolova, Cristina
    Gamboa-Cardenas, Rocio V.
    Elera-Fitzcarrald, Claudia
    Rodriguez-Bellido, Zoila
    Pastor-Asurza, Cesar A.
    Perich-Campos, Risto
    Alarcon, Graciela S.
    Ugarte-Gil, Manuel F.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2024, 30 (06) : 235 - 238
  • [9] De novo lupus nephritis during treatment with belimumab
    Parodis, Ioannis
    Vital, Edward M.
    Hassan, Sabih-Ul
    Jonsen, Andreas
    Bengtsson, Anders A.
    Eriksson, Per
    Leonard, Dag
    Gunnarsson, Iva
    Ronnblom, Lars
    Sjowall, Christopher
    RHEUMATOLOGY, 2021, 60 (09) : 4348 - 4354
  • [10] Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares
    Zisa, Diane
    Zhang-Sun, Jeffrey
    Christos, Paul J.
    Kirou, Kyriakos A.
    LUPUS, 2024, 33 (09) : 938 - 947
12345